Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 11;12(5):1204.
doi: 10.3390/cancers12051204.

Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends

Affiliations
Review

Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends

Michelle D Bardis et al. Cancers (Basel). .

Abstract

Prostate carcinoma is one of the most prevalent cancers worldwide. Multiparametric magnetic resonance imaging (mpMRI) is a non-invasive tool that can improve prostate lesion detection, classification, and volume quantification. Machine learning (ML), a branch of artificial intelligence, can rapidly and accurately analyze mpMRI images. ML could provide better standardization and consistency in identifying prostate lesions and enhance prostate carcinoma management. This review summarizes ML applications to prostate mpMRI and focuses on prostate organ segmentation, lesion detection and segmentation, and lesion characterization. A literature search was conducted to find studies that have applied ML methods to prostate mpMRI. To date, prostate organ segmentation and volume approximation have been well executed using various ML techniques. Prostate lesion detection and segmentation are much more challenging tasks for ML and were attempted in several studies. They largely remain unsolved problems due to data scarcity and the limitations of current ML algorithms. By contrast, prostate lesion characterization has been successfully completed in several studies because of better data availability. Overall, ML is well situated to become a tool that enhances radiologists' accuracy and speed.

Keywords: artificial intelligence; deep learning; machine learning; neural network; prostate carcinoma; prostate mpMRI.

PubMed Disclaimer

Conflict of interest statement

Author Peter D. Chang, MD, is a co-founder and shareholder of Avicenna.ai, a medical imaging startup. Author Daniel S. Chow, MD, is a shareholder of Avicenna.ai, a medical imaging startup, and a grant recipient from Cannon Inc. The other authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Relationship between artificial intelligence, machine learning, and deep learning. Artificial intelligence is an umbrella term that includes machine learning and deep learning. Deep learning is a hyponym of machine learning.
Figure 2
Figure 2
Machine learning versus deep learning used for multiparametric magnetic resonance imaging (mpMRI) sequence identification. In machine learning, the computer receives inputs of mpMRI images and goes through feature extraction specific to the different sequences of T2-weighted (T2W), diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE). Then, the computer is trained on additional images and is able to identify the correct sequence as an output. Deep learning differs from machine learning in that feature extraction and training can be done simultaneously to produce the output.
Figure 3
Figure 3
Prostate organ segmentation performed by machine learning methods. The computer takes multiparametric magnetic resonance imaging images as inputs and applies the developed machine learning algorithm to correctly identify the borders of the prostate.
Figure 4
Figure 4
Prostate lesion detection using machine learning methods. The computer takes multiparametric magnetic resonance imaging images of the prostate as inputs and applies the developed machine learning algorithm to correctly localize lesions in the prostate.
Figure 5
Figure 5
Prostate lesion segmentation using machine learning techniques. The computer takes multiparametric magnetic resonance imaging images of the prostate as inputs and applies the developed machine learning algorithm to correctly identify the borders of the lesion.
Figure 6
Figure 6
Prostate lesion characterization using machine-learning techniques. The computer receives multiparametric magnetic imaging images of prostate lesions and applies the developed machine learning algorithm to categorize the lesion as clinically significant prostate cancer or non-significant prostate cancer.

References

    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA Cancer J. Clin. 2017;67:7–30. doi: 10.3322/caac.21387. - DOI - PubMed
    1. Hugosson J., Carlsson S. Overdetection in screening for prostate cancer. Curr. Opin. Urol. 2014;24:256–263. doi: 10.1097/MOU.0000000000000054. - DOI - PubMed
    1. Schröder F.H., Hugosson J., Roobol M.J., Tammela T.L., Ciatto S., Nelen V., Kwiatkowski M., Lujan M., Lilja H., Zappa M., et al. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 2009;360:1320–1328. doi: 10.1056/NEJMoa0810084. - DOI - PubMed
    1. Oberlin D.T., Casalino D.D., Miller F.H., Meeks J.J. Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer. Abdom. Radiol. (Ny) 2017;42:1255–1258. doi: 10.1007/s00261-016-0975-5. - DOI - PubMed
    1. Monni F., Fontanella P., Grasso A., Wiklund P., Ou Y.C., Randazzo M., Rocco B., Montanari E., Bianchi G. Magnetic resonance imaging in prostate cancer detection and management: A systematic review. Minerva. Urol. Nefrol. 2017;69:567–578. doi: 10.23736/S0393-2249.17.02819-3. - DOI - PubMed